Pfs230D1-Ferritin

Nichole D Salinas1, Rui Ma1, Holly McAleese2

  • 1Host-Pathogen Interactions and Structural Vaccinology Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Vaccines
|May 25, 2024
PubMed
概括

一种新型疟疾疫苗使用Pfs230抗原与费里丁纳米颗粒融合,显示出有前途. 这种阻止传播的疫苗具有高度免疫性,可以改善疟疾控制制造.